Welcome to our dedicated page for Danaher news (Ticker: DHR), a resource for investors and traders seeking the latest updates and insights on Danaher stock.
Danaher Corporation reports developments tied to its global life sciences and diagnostics businesses, where its companies provide scientific technologies, clinical diagnostic systems and tools used in discovery, diagnosis and therapy development. Recurring updates include earnings calls, dividend actions, investor conference appearances and product or regulatory milestones from operating businesses such as Beckman Coulter Diagnostics.
Company news also covers diagnostic assays, immunoassay analyzer platforms, clinical-laboratory workflows and the Danaher Business System, which the company uses as an operating framework across its businesses. Additional recurring themes include shareholder voting matters, governance updates and capital-structure disclosures.
Summary not available.
Danaher Corporation (NYSE: DHR) has announced its second-quarter 2020 earnings conference call scheduled for July 23, 2020, at 8:00 a.m. ET. The call will be accessible via a webcast on Danaher's website, where an accompanying slide presentation will also be available. A replay of the call will remain accessible until August 6, 2020. Danaher is known for its innovation in science and technology with a strong presence in health care and environmental sectors, underpinned by the Danaher Business System.